ERBB4 and neoplasm: Therefore, the abrogation of tumor suppressor activity of the constitutively-active ErbB4 Q646C mutant by the V673I, LL783/4AA, and L985A mutants appears to be due to the disruption of the gamma-secretase cleavage site, the amino-terminal steroid hormone binding motif, and the BH3 motif, respectively.